Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001171843-21-006732
Filing Date
2021-09-30
Accepted
2021-09-30 16:34:43
Documents
4
Effectiveness Date
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM S-8 fs8_080621.htm S-8 54102
2 EXHIBIT 5.1 exh_51.htm EX-5.1 7720
3 EXHIBIT 23.1 exh_231.htm EX-23.1 3258
4 EXHIBIT 99.1 exh_991.htm EX-99.1 85481
  Complete submission text file 0001171843-21-006732.txt   151598
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-259919 | Film No.: 211295469
SIC: 2836 Biological Products, (No Diagnostic Substances)